From Medscape Gastroenterology

Coverage from the

American College of Gastroenterology (ACG) 2016 Annual Scientific Meeting

October 14 - 19, 2016; Las Vegas, Nevada

October 14 - 19, 2016 Las Vegas, Nevada
  • ACG Spike in C difficile After Roux-en-Y Gastric Bypass Rates of Clostridium difficile infection are elevated after gastric bypass surgery, new research shows; this could be related to changes in distal gut bacteria, specialists speculate.
  • ACG Remimazolam Allows Speedy Recovery After Colonoscopy For outpatient colonoscopy, the new benzodiazepine provides adequate sedation, and recovery is faster than with the alternative, owing to its short half-life, new research shows.
  • ACG Eosinophilic Esophagitis Antibody Therapy Shows Promise An investigative anti-interleukin-13 antibody decreased 16-week eosinophilic counts in a phase 2 study of patients with active eosinophilic esophagitis.


News Feature

Conference News

Popular News from ACG 2015

Medscape Gastroenterology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentary

Medscape Board at the Podium

  • David Carr-Locke, MD
    Mount Sinai Beth Israel Medical Center, New York
    Presentation: Case series on an emerging procedure: Endoscopic removal of uncovered biliary self-expandable metal stents
    Date: October 16, 2016
  • Stephen Hanauer, MD
    Northwestern University Feinberg School of Medicine, Chicago, Illinois
    Presentation: Update on biosimilars and new agents in the management of IBD
    Date: October 14, 2016
  • David Johnson, MD
    Eastern Virginia Medical School, Norfolk, Virginia
    Presentation: Multi-year safety and durability of PEG-J used for continuous infusion of levodopa-carbidopa intestinal gel in ambulatory Parkinson's disease patients: Year 2 and beyond
    Date: October 16, 2016
  • Brian Lacy, MD, PhD
    Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
    Presentation: Efficacy and safety of eluxadoline in IBS-D patients who report prior inadequate symptom control with loperamide
    Date: October 17, 2016
  • Bret Lashner, MD
    Cleveland Clinic Lerner College of Medicine, Ohio
    Presentation: Fecal microbiota transplantation in your practice
    Date: October 18, 2016
  • Nancy Reau, MD
    Rush University Medical Center, Chicago, Illinois
    Presentation: Non-alcoholic fatty liver disease (NAFLD) recognition: Are we doing enough?
    Date: October 16, 2016
  • Douglas Rex, MD
    University Hospital, Indianapolis, Indiana
    Presentation: Edible colon preparation shows excellent efficacy, safety and tolerability in a phase 2, randomized trial
    Date: October 17, 2016

Previous Coverage